TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Lifeline Pharma AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
18,735
|
18,096
|
30,690 |
| Financial expenses |
821
|
488
|
360 |
| Earnings before taxes |
-1,395
|
794
|
-2,468 |
| Total assets |
16,929
|
12,791
|
14,645 |
| Current assets |
16,297
|
12,232
|
14,133 |
| Current liabilities |
5,652
|
8,867
|
14,243 |
| Equity capital |
-1,655
|
-261
|
-1,371 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-9.8%
|
-2.0%
|
-9.4% |
| Turnover per employee |
6,032
|
10,230 | |
| Profit as a percentage of turnover |
-7.4%
|
4.4%
|
-8.0% |
| Return on assets (ROA) |
-3.4%
|
10.0%
|
-14.4% |
| Current ratio |
288.3%
|
137.9%
|
99.2% |
| Return on equity (ROE) |
84.3%
|
-304.2%
|
180.0% |
| Change turnover |
639
|
-12,594
|
-5,388 |
| Change turnover % |
4%
|
-41%
|
-15% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.